Article
Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models
2021-03-30
Abstract excerpt
<h4>ABSTRACT</h4> Congenital erythropoietic porphyria (CEP) is a rare genetic disorder leading to accumulation of uro/coproporphyrin-I in tissues due to inhibition of uroporphyrinogen-III synthase. Clinical manifestations of CEP include bone fragility, severe photosensitivity and photomutilation. Currently there is no specific treatment for CEP, except bone marrow transplantation, and there is an unmet need for t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4e63394d-cf08-5fd6-a9e4-32684d2ee1f4
- DOI
- 10.1101/2021.03.30.437658
